UHS UNIVERSAL HEALTH SERVICES INC
Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 352915 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.0%
TTM net income YoY6.3%
TTM EPS YoY13.7%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR29.3%
Margins
Gross margin—
Operating margin10.8%
Net margin8.0%
FCF margin6.1%
EBITDA margin14.5%
Returns
ROE19.8%
ROA9.0%
ROIC (approx.)12.2%
Asset turnover1.13x
Leverage & solvency
Liabilities / assets55.0%
Debt / equity0.75x
Current ratio1.37x
Interest coverage11.34x
Cash quality & payout
Operating cash flow / net income1.41x
Accruals ratio-3.7%
Payout ratio3.3%
Capex / revenue5.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $17.36B | $15.83B |
| Operating income | $1.99B | $1.68B |
| Interest expense | $156.07M | $186.11M |
| Pretax income | $1.97B | $1.50B |
| Income tax | $460.96M | $334.83M |
| Net income | $1.49B | $1.14B |
| EBITDA | $2.61B | $2.27B |
| EPS (basic) | 23.42 | 17.16 |
| EPS (diluted) | 23.10 | 16.82 |
| Dividends declared per share | 0.80 | 0.80 |
| Weighted avg. shares (diluted) | 64.46M | 67.90M |
| Balance sheet | ||
| Cash & equivalents | $137.80M | $125.98M |
| Receivables | $2.60B | $2.18B |
| Current assets | $3.41B | $2.82B |
| PP&E, net | $7.01B | $6.57B |
| Goodwill | $3.99B | $3.93B |
| Intangibles | $75.88M | $76.27M |
| Total assets | $15.53B | $14.47B |
| Current liabilities | $3.24B | $2.21B |
| Short-term debt | $748.16M | $40.06M |
| Long-term debt | $4.00B | $4.46B |
| Total debt | $4.75B | $4.50B |
| Total liabilities | $8.12B | $7.71B |
| Shareholders' equity | $7.28B | $6.67B |
| Net debt | $4.61B | $4.38B |
| Cash flow statement | ||
| Operating cash flow | $1.86B | $2.07B |
| Capital expenditure | $1.02B | $943.81M |
| Free cash flow | $849.25M | $1.12B |
| Investing cash flow | -$1.07B | -$911.11M |
| Financing cash flow | -$749.73M | -$1.14B |
| Depreciation & amortization | $618.74M | $584.83M |
| Stock-based compensation | $95.69M | $99.35M |
| Dividends paid | $51.27M | $53.35M |
| Share buybacks | $967.95M | $670.75M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.